Sunday, April 16, 2017

Synthetic Cannabinoids

St Emlyn´s - By Richard Carden - April 15, 2017
..."SCRAs are common, and becoming increasingly so globally. Acute specialties are switched on and are becoming increasingly aware of the burden of this problem. In the UK, the IONA study and the WEDINOS project are aiming to further characterise the problem and the agents at play. An important document to read, if you are interested, was published in 2009 by the European Monitoring Centre for Drugs and Drug Addiction can be found here.
Vulnerable groups are especially likely to affected by the availability of SCRAs, especially the homeless, adolescents and prisoners. Bear that in mind when confronted with unexplainable physiology. It is often largely irrelevant to ask what an individual has taken, but as the signs and symptoms do not fit any one particular toxidrome, it may help make a diagnosis.
Without wanting to precipitate a debate; the now-illegality of these substances mean even less quality control in their production. We really don’t know how or where they are being prepared, or what other ingredients are being added. All these factors create a perfect storm for overdose and emergent toxicological presentations. Treatment remains a very grey area – so please read the articles for yourself and contact your local poisons information service if you find yourself needing to treat one of these patients in real life."